0,835  0,007  Caspase 9 stimulant
0,819  0,004  Tubulin antagonist
0,785  0,009  Antineoplastic (lung cancer)
0,784  0,010  Antineoplastic (breast cancer)
0,774  0,009  Antineoplastic (colorectal cancer)
0,768  0,009  Antineoplastic (colon cancer)
0,689  0,003  Alpha tubulin antagonist
0,681  0,011  Prostate cancer treatment
0,660  0,005  Antimitotic
0,688  0,033  Apoptosis agonist
0,653  0,009  Antineoplastic (cervical cancer)
0,650  0,008  Cardiovascular analeptic
0,643  0,003  Beta tubulin antagonist
0,610  0,015  Vasodilator, peripheral
0,592  0,011  Caspase 3 stimulant
0,595  0,013  Antineoplastic (melanoma)
0,579  0,011  Antineoplastic (non-small cell lung cancer)
0,582  0,017  Antineoplastic (ovarian cancer)
0,568  0,012  NOS2 expression inhibitor
0,576  0,022  Aldehyde oxidase inhibitor
0,562  0,015  Antineoplastic (pancreatic cancer)
0,554  0,012  Antineoplastic (multiple myeloma)
0,548  0,020  5 Hydroxytryptamine release stimulant
0,542  0,015  Ulceration
0,552  0,031  Antileukemic
0,552  0,034  TNF expression inhibitor
0,551  0,035  Antineoplastic (solid tumors)
0,521  0,006  Antineoplastic (squamous cell carcinoma)
0,521  0,016  Antineoplastic (glioma)
0,521  0,024  Antihypercholesterolemic
0,502  0,005  Calcium channel activator
0,533  0,040  Transcription factor NF kappa B inhibitor
0,499  0,008  P-glycoprotein inhibitor
0,490  0,009  Antineoplastic (carcinoma)
0,511  0,030  Antipruritic, allergic
0,490  0,015  Antineoplastic (glioblastoma multiforme)
0,480  0,014  UGT2B4 substrate
0,455  0,014  RNA-directed DNA polymerase inhibitor
0,463  0,048  CYP3A4 substrate
0,422  0,007  Pneumotoxic
0,441  0,028  UGT1A9 substrate
0,423  0,011  Hepatoprotectant
0,411  0,006  Acetylcholinesterase inhibitor
0,412  0,014  Antineoplastic (sarcoma)
0,429  0,035  Hepatic disorders treatment
0,399  0,008  Antineoplastic (gastric cancer)
0,411  0,022  Antineoplastic (renal cancer)
0,397  0,010  Cholinergic
0,396  0,016  Antineoplastic (bladder cancer)
0,403  0,027  Antipyretic
0,393  0,019  Sodium/bile acid cotransporter inhibitor
0,399  0,040  Antineoplastic (brain cancer)
0,393  0,037  Vasodilator, coronary
0,419  0,067  5 Hydroxytryptamine release inhibitor
0,371  0,020  5 Hydroxytryptamine uptake stimulant
0,362  0,013  VCAM1 expression inhibitor
0,374  0,032  Tumour necrosis factor alpha release inhibitor
0,390  0,048  FMO1 substrate
0,364  0,023  Abortion inducer
0,369  0,029  Nitric oxide antagonist
0,372  0,038  Cytostatic
0,362  0,033  Chemopreventive
0,378  0,049  ICAM1 expression inhibitor
0,394  0,065  Immunosuppressant
0,352  0,024  Sedative
0,346  0,020  Antimutagenic
0,347  0,026  Cyclic AMP phosphodiesterase inhibitor
0,345  0,030  Antineoplastic (lymphocytic leukemia)
0,356  0,043  Hypoxia-inducible factor 1 alpha inhibitor
0,383  0,071  CYP2C19 inhibitor
0,358  0,047  CTGF expression inhibitor
0,355  0,045  Antioxidant
0,312  0,004  UGT2B10 substrate
0,349  0,041  DNA damaging
0,357  0,050  Spasmolytic
0,335  0,029  GST M1-1 substrate
0,334  0,029  Platelet aggregation inhibitor
0,344  0,044  Sensitization
0,338  0,042  Proliferative diseases treatment
0,350  0,056  Respiratory analeptic
0,318  0,025  Antihypotensive
0,312  0,022  Contraceptive
0,306  0,018  Lipid peroxidase inhibitor
0,322  0,035  Sigma receptor agonist
0,313  0,027  Tyrosine 3 hydroxylase inhibitor
0,343  0,060  AR expression inhibitor
0,310  0,029  UGT1A4 substrate
0,321  0,041  Vasodilator
0,316  0,040  UGT1A6 substrate
0,341  0,068  Cholesterol antagonist
0,315  0,045  Antineoplastic (liver cancer)
0,292  0,023  Antipruritic, non-allergic
0,300  0,031  Muscle relaxant
0,330  0,072  Antithrombotic
0,278  0,025  Neurotrophic factor enhancer
0,277  0,025  Skeletal muscle relaxant
0,302  0,051  Free radical scavenger
0,272  0,022  UGT2B15 substrate
0,309  0,060  Teratogen
0,280  0,031  UGT2B7 substrate
0,297  0,052  Cytotoxic
0,298  0,054  Transcription factor STAT3 inhibitor
0,251  0,008  Microtubule formation inhibitor
0,293  0,054  Cardiodepressant
0,309  0,070  Analeptic
0,256  0,019  Antineoplastic (bone cancer)
0,295  0,059  Chemoprotective
0,239  0,004  Acetylcholine release stimulant
0,241  0,008  Arachidonic acid antagonist
0,253  0,020  LDLR expression enhancer
0,261  0,028  UGT1A3 substrate
0,292  0,062  CYP1A2 inhibitor
0,335  0,106  Histamine release inhibitor
0,276  0,048  5 Hydroxytryptamine 1E antagonist
0,286  0,058  Antiprotozoal (Leishmania)
0,271  0,045  Antineoplastic enhancer
0,264  0,044  Anesthetic general
0,259  0,044  UGT1A1 substrate
0,291  0,075  Cardioprotectant
0,245  0,029  Amylase inhibitor
0,243  0,030  Interferon gamma antagonist
0,237  0,024  UGT2B9 substrate
0,266  0,053  Amyloid beta aggregation inhibitor
0,261  0,050  Antiparkinsonian, rigidity relieving
0,285  0,082  Antineoplastic (osteosarcoma)
0,229  0,032  Protein kinase stimulant
0,225  0,029  Toxic, respiratory center
0,274  0,078  CYP2C19 substrate
0,226  0,032  Succinate dehydrogenase inhibitor
0,263  0,069  Embryotoxic
0,276  0,083  Lipoxygenase inhibitor
0,299  0,107  CYP2C9 substrate
0,206  0,017  Alpha 2c adrenoreceptor antagonist
0,258  0,070  Gastrin inhibitor
0,200  0,013  Photosensitizer
0,206  0,022  Alpha 2b adrenoreceptor antagonist
0,224  0,039  3C-like protease (Human coronavirus) inhibitor
0,276  0,094  12-Lipoxygenase inhibitor
0,281  0,099  Apoptosis antagonist
0,217  0,035  VEGF expression inhibitor
0,202  0,021  Butyrylcholinesterase inhibitor
0,229  0,048  CYP2B6 inhibitor
0,210  0,030  Carcinogenic, group 1
0,294  0,114  GST A substrate
0,211  0,031  NADPH oxidase inhibitor
0,192  0,012  Multidrug resistance-associated protein 1 inhibitor
0,197  0,020  Cyclooxygenase 3 inhibitor
0,183  0,006  UGT2B11 substrate
0,213  0,036  Melanin inhibitor
0,249  0,075  Antidiabetic symptomatic
0,226  0,053  Nitric-oxide synthase stimulant
0,236  0,064  Psychostimulant
0,247  0,077  Superoxide dismutase inhibitor
0,201  0,032  Antiprotozoal (Coccidial)
0,191  0,025  Antieczematic
0,202  0,037  Antiseptic
0,199  0,036  Genotoxic
0,185  0,024  Expectorant
0,290  0,131  Antiprotozoal
0,275  0,117  Antiprotozoal (Plasmodium)
0,339  0,181  Antiinflammatory
0,173  0,018  Antineoplastic (uterine cancer)
0,177  0,023  Choleretic
0,229  0,075  Antineoplastic (lymphoma)
0,172  0,018  Calcium antagonist
0,164  0,012  Antifungal (Pneumocystis)
0,232  0,079  Antiamyloidogenic
0,194  0,042  Phobic disorders treatment
0,243  0,092  Transcription factor STAT inhibitor
0,172  0,021  Contraceptive female
0,265  0,119  Antineoplastic (small cell lung cancer)
0,176  0,031  Cystathionine beta-synthase inhibitor
0,159  0,014  Contraceptive male
0,219  0,075  Antiulcerative
0,191  0,048  Antiviral (Influenza A)
0,208  0,065  Non-steroidal antiinflammatory agent
0,197  0,055  Tumour necrosis factor antagonist
0,158  0,016  Antiprotozoal (Toxoplasma)
0,175  0,034  Cholesterol synthesis inhibitor
0,180  0,040  Antifungal enhancer
0,176  0,036  Toll-Like receptor 2 antagonist
0,226  0,087  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,184  0,046  Heat shock protein 90 antagonist
0,160  0,022  Antiviral (Influenza B)
0,256  0,118  Angiogenesis inhibitor
0,176  0,041  CF transmembrane conductance regulator agonist
0,188  0,054  Antirickettsial
0,170  0,036  Adenylate cyclase stimulant
0,148  0,015  Dopamine D1 antagonist
0,193  0,061  Lipocortins synthesis antagonist
0,163  0,031  Coagulant
0,158  0,025  Alpha 2 adrenoreceptor antagonist
0,150  0,018  Anabolic
0,141  0,010  Glycine receptor antagonist
0,223  0,093  Vascular (periferal) disease treatment
0,152  0,022  Androgen antagonist
0,240  0,111  NOS3 expression inhibitor
0,183  0,054  ATPase inhibitor
0,221  0,093  DNA synthesis inhibitor
0,212  0,086  Hypolipemic
0,200  0,075  Antiviral (Influenza)
0,161  0,036  Pregnane X receptor agonist
0,155  0,031  Ca2+-transporting ATPase inhibitor
0,196  0,073  Platelet adhesion inhibitor
0,146  0,023  Electron transport complex I inhibitor
0,150  0,028  Antineoplastic alkaloid
0,235  0,113  CYP1A2 substrate
0,227  0,106  Antiosteoporotic
0,240  0,120  Bone diseases treatment
0,177  0,058  Cytidine deaminase inhibitor
0,176  0,058  Acaricide
0,177  0,060  Prostate disorders treatment
0,147  0,034  Mucolytic
0,172  0,060  Uterine stimulant
0,145  0,034  Constipation treatment
0,131  0,021  Inducible nitric-oxide synthase inhibitor
0,149  0,040  Vanilloid 1 agonist
0,125  0,017  Aromatase inhibitor
0,268  0,160  Antibacterial
0,190  0,082  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,134  0,026  GST T1-1 substrate
0,166  0,059  Hair growth stimulant
0,230  0,124  Antifungal
0,121  0,015  Granulocyte macrophage colony stimulating factor agonist
0,115  0,010  5 Hydroxytryptamine 2A agonist
0,216  0,112  Lipoprotein disorders treatment
0,160  0,057  Anesthetic
0,148  0,046  Antitussive
0,126  0,025  Glutamate (mGluR7) agonist
0,150  0,048  Antihelmintic (Trematoda)
0,171  0,072  Antipruritic
0,130  0,032  Prolactin inhibitor
0,148  0,050  Topoisomerase II inhibitor
0,189  0,091  Antihypertriglyceridemic
0,133  0,035  Antineoplastic antibiotic
0,124  0,027  SULT1E1 substrate
0,102  0,008  SULT2A1 substrate
0,181  0,088  Antiarrhythmic
0,098  0,006  Calcium channel P-type blocker
0,131  0,039  UGT2B1 substrate
0,138  0,046  5 Hydroxytryptamine 2B antagonist
0,126  0,035  Breast cancer-resistant protein inhibitor
0,097  0,007  Postcoital contraceptive
0,118  0,029  Phosphodiesterase 4D inhibitor
0,100  0,011  Heat shock protein 90 beta antagonist
0,096  0,008  Transcription factor RelA inhibitor
0,129  0,041  Myasthenia Gravis treatment
0,152  0,065  Antiparkinsonian, tremor relieving
0,097  0,010  Topoisomerase II beta inhibitor
0,145  0,057  Cocaine dependence treatment
0,187  0,099  Antialcoholic
0,137  0,053  Platelet activating factor antagonist
0,114  0,031  Alpha 2a adrenoreceptor antagonist
0,213  0,130  CYP2D6 substrate
0,140  0,057  Antihemorrhagic
0,172  0,091  UDP-glucuronosyltransferase substrate
0,123  0,041  Dementia treatment
0,156  0,074  Eye irritation, high
0,111  0,029  Glutamate release inhibitor
0,107  0,027  Phosphodiesterase 3A inhibitor
0,114  0,035  Paget's disease treatment
0,128  0,049  SULT1A1 substrate
0,102  0,023  Narcotic antagonist
0,094  0,017  Androgen agonist
0,107  0,030  ATPase (Vacuolar H+) inhibitor
0,118  0,041  Vascular dementia treatment
0,245  0,168  15-Lipoxygenase inhibitor
0,109  0,033  Interleukin 5 antagonist
0,207  0,131  Radiosensitizer
0,085  0,010  Progesterone antagonist
0,128  0,054  5 Hydroxytryptamine 2 antagonist
0,097  0,024  Phosphodiesterase III inhibitor
0,125  0,052  Endometrios treatment
0,110  0,038  Phosphodiesterase IV inhibitor
0,131  0,058  Antiviral (Papilloma)
0,122  0,051  Estrogen antagonist
0,162  0,091  Carcinogenic
0,130  0,059  Alkylator
0,116  0,046  GST P1-1 substrate
0,086  0,018  Exportin-1 inhibitor
0,123  0,055  TRPA1 agonist
0,141  0,073  Heat shock protein 70 antagonist
0,190  0,122  Hypoglycemic
0,097  0,029  CDC25A inhibitor
0,146  0,080  Raynaud's phenomenon treatment
0,095  0,029  Ca(v)3.1 blocker
0,077  0,011  Anesthetic inhalation
0,077  0,011  Ryanodine receptor antagonist
0,092  0,027  Glycine receptor agonist
0,145  0,080  GABA C receptor rho-2 antagonist
0,150  0,086  Heat shock protein 90 alpha antagonist
0,079  0,015  5 Hydroxytryptamine 2 agonist
0,113  0,050  Alpha adrenoreceptor antagonist
0,101  0,037  Antileprosy
0,142  0,080  Antidote
0,093  0,035  Keratolytic
0,071  0,013  Estrogen receptor alpha agonist
0,247  0,189  Alpha-glucosidase inhibitor
0,070  0,014  Pregnane X receptor antagonist
0,111  0,056  GABA C receptor agonist
0,126  0,072  Antihyperlipoproteinemic
0,078  0,024  Estrogen agonist
0,089  0,036  Estrogen receptor alpha antagonist
0,108  0,055  Sulfotransferase substrate
0,095  0,043  Antiviral (Trachoma)
0,099  0,047  Restless leg syndrome treatment
0,135  0,084  SULT1A3 substrate
0,090  0,040  Estrogen-related receptor beta agonist
0,098  0,048  5 Hydroxytryptamine 2A antagonist
0,079  0,029  Glutamate (mGluR7) antagonist
0,094  0,044  Topoisomerase II alpha inhibitor
0,071  0,021  Lipocortins synthesis agonist
0,066  0,016  Aldosterone antagonist
0,124  0,075  Antibacterial (Helicobacter pylori)
0,109  0,060  DOPA decarboxylase inhibitor
0,092  0,044  mTOR complex 2 inhibitor
0,119  0,072  Antiprotozoal (Amoeba)
0,083  0,036  Calcium channel L-type blocker
0,089  0,043  Dopamine antagonist
0,102  0,056  Nitric-oxide synthase inhibitor
0,059  0,013  Guanylate cyclase inhibitor
0,076  0,030  Glutamate (mGluR6) antagonist
0,111  0,065  GABA receptor agonist
0,125  0,079  Antiprotozoal (Trichomonas)
0,055  0,010  5 Hydroxytryptamine 2B agonist
0,057  0,012  Dihydrofolate reductase inhibitor
0,181  0,137  Antiprotozoal (Trypanosoma)
0,094  0,050  Ornithine decarboxylase inhibitor
0,101  0,057  Tourette's syndrome treatment
0,053  0,009  Melatonin 2 agonist
0,063  0,021  Prolyl endopeptidase inhibitor
0,092  0,051  Tocolytic
0,079  0,038  Dopamine agonist
0,083  0,041  Antidote, organophosphates
0,134  0,093  Antidiarrheal
0,085  0,045  Na+ K+ transporting ATPase inhibitor
0,092  0,052  Carcinogenic, group 2A
0,048  0,009  Tubulin agonist
0,106  0,069  GABA C receptor antagonist
0,077  0,041  Dopamine D2 antagonist
0,114  0,078  Antiviral (Hepatitis B)
0,062  0,027  Sigma receptor antagonist
0,091  0,056  Antidote, mercury
0,085  0,050  Alpha 1 adrenoreceptor antagonist
0,062  0,028  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,084  0,050  Acetylcholine nicotinic antagonist
0,135  0,101  Prostatic (benign) hyperplasia treatment
0,111  0,077  Carcinogenic, group 3
0,064  0,030  Postmenopausal disorders treatment
0,044  0,011  Melatonin receptor 1A agonist
0,146  0,113  Neurotensin receptor agonist
0,170  0,137  5 Hydroxytryptamine 3E antagonist
0,059  0,027  Nicotinic alpha3beta2 receptor antagonist
0,044  0,012  Melatonin agonist
0,120  0,088  Calcium channel blocker
0,050  0,019  5-Alpha-reductase inhibitor
0,100  0,070  Topoisomerase I inhibitor
0,053  0,023  Dopamine D5 antagonist
0,048  0,019  Dopamine D5 agonist
0,033  0,004  Progesterone receptor B antagonist
0,053  0,025  Dopamine D2 agonist
0,037  0,010  Nicotinic alpha4beta2 receptor agonist
0,051  0,024  Potassium channel small-conductance Ca-activated blocker
0,038  0,011  Melatonin antagonist
0,099  0,072  AMP-activated protein kinase stimulant
0,246  0,219  Alzheimer's disease treatment
0,120  0,094  Neurotrophic factor
0,038  0,012  Nicotinic alpha3beta4 receptor agonist
0,115  0,089  Nav1.2 sodium channel blocker
0,199  0,173  CYP3A4 inhibitor
0,071  0,046  5 Hydroxytryptamine 1A antagonist
0,073  0,048  Histidine decarboxylase inhibitor
0,100  0,076  Antifungal (Aspergillus)
0,064  0,040  Phosphodiesterase 1C inhibitor
0,053  0,028  Factor III inhibitor
0,147  0,123  Sepsis treatment
0,153  0,129  Antiparasitic
0,057  0,033  Protein 50S ribosomal subunit inhibitor
0,064  0,041  Dopamine D3 antagonist
0,087  0,064  Actinic keratosis treatment
0,128  0,105  Neuropeptide Y1 antagonist
0,048  0,026  Estradiol 17 beta-dehydrogenase inhibitor
0,095  0,073  Estrogen receptor beta antagonist
0,107  0,087  Growth stimulant
0,086  0,065  Phosphodiesterase I inhibitor
0,062  0,042  Antimycoplasmal
0,105  0,085  Autism spectrum disorders treatment
0,097  0,078  Excitatory amino acid transporter EAAC1 inhibitor
0,059  0,041  Alpha 1d adrenoreceptor antagonist
0,069  0,051  Alpha 1a adrenoreceptor antagonist
0,060  0,042  Alpha 2 adrenoreceptor agonist
0,121  0,104  Mutagenic
0,090  0,073  Bile acid receptor antagonist
0,025  0,008  Melatonin 1 antagonist
0,074  0,058  Antitreponemal
0,027  0,011  Dopamine D1 agonist
0,167  0,151  Interleukin agonist
0,053  0,037  Nicotinic receptor alpha7 subunit antagonist
0,039  0,024  Vanilloid 3 antagonist
0,020  0,005  Melatonin receptor 1A antagonist
0,036  0,022  Adenosine uptake inhibitor
0,068  0,054  Alpha 1b adrenoreceptor antagonist
0,097  0,083  Protein kinase C gamma inhibitor
0,169  0,155  Radioprotector
0,106  0,093  Alpha-N-acetylglucosaminidase inhibitor
0,034  0,021  Melatonin 1 agonist
0,059  0,046  5 Hydroxytryptamine 7 antagonist
0,054  0,042  5 Hydroxytryptamine 7 agonist
0,070  0,058  Carbonic anhydrase XIII inhibitor
0,019  0,007  NMDA receptor phencyclidine site antagonist
0,066  0,054  Andropause treatment
0,058  0,048  Transcription factor AP-1 inhibitor
0,179  0,169  Flavin-containing monooxygenase substrate
0,057  0,047  Potassium channel (Ca-activated) blocker
0,027  0,017  Toll-Like receptor 4 agonist
0,100  0,090  Beta amyloid protein antagonist
0,070  0,061  NAD(P)H dehydrogenase (quinone) inhibitor
0,014  0,005  Melatonin 2 antagonist
0,049  0,040  5 Hydroxytryptamine 4 antagonist
0,058  0,049  5 Hydroxytryptamine 5A antagonist
0,085  0,076  5-Lipoxygenase inhibitor
0,181  0,172  CYP2D6 inhibitor
0,116  0,108  Mannose-6-phosphate isomerase inhibitor
0,012  0,005  Progesterone receptor A antagonist
0,146  0,139  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,104  0,096  CNS active muscle relaxant
0,067  0,060  Antibiotic
0,031  0,023  Glucocorticoid antagonist
0,036  0,029  Glutamate (mGluR8) agonist
0,211  0,204  Antineoplastic (endocrine cancer)
0,022  0,015  Estrone sulfatase inhibitor
0,065  0,059  5 Hydroxytryptamine 1 antagonist
0,027  0,021  Hedgehog signaling activator
0,069  0,063  Nicotinic alpha4beta2 receptor antagonist
0,120  0,114  Hemostatic
0,102  0,097  Retinopathy treatment
0,039  0,034  Kainate receptor agonist
0,126  0,121  Liver fibrosis treatment
0,145  0,140  Insulin sensitizer
0,018  0,013  Antibiotic Trimethoprim-like
0,138  0,133  Phospholipase C inhibitor
0,046  0,042  Squalene epoxidase inhibitor
0,073  0,069  MAP kinase kinase 7 inhibitor
0,072  0,068  Carbonic anhydrase VI inhibitor
0,043  0,039  CC chemokine 4 receptor antagonist
0,134  0,131  Antihelmintic
0,016  0,012  Nicotinic alpha4 receptor agonist
0,053  0,050  5 Hydroxytryptamine 5 antagonist
0,023  0,021  Sigma 2 receptor antagonist
0,030  0,028  Glutamate (mGluR3) agonist
0,188  0,187  FMO3 substrate
0,082  0,081  Protein kinase C zeta inhibitor
0,020  0,019  CYP24 inhibitor
0,056  0,056  Hyperparathyroidism treatment
0,036  0,036  Liver X receptor alpha agonist
0,083  0,083  Sphingomyelinase inhibitor
0,041  0,041  Potassium channel Kv1.3 blocker

